Related references
Note: Only part of the references are listed.Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
Dan Yang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Aza-Flavanone Diminishes Parkinsonism in the Drosophila melanogaster Parkin Mutant
Chitrakshi Pant et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Mutant IDH1 inhibitors activate pSTAT3-Y705 leading to an increase in BCAT1 and YKL-40 levels in mutant IDH1-expressing cells
Debanjan Bhattacharjee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
APC/C CDH1 ubiquitinates IDH2 contributing to ROS increase in mitosis
Surbhi Lambhate et al.
CELLULAR SIGNALLING (2021)
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy
Sara Ranjbarvaziri et al.
CIRCULATION (2021)
BORIS/CTCFL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma
Venkata Krishna Kanth Makani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Bcl-2 Is Involved in Cardiac Hypertrophy throu PI3K-Akt Pathway
Xianwei Meng et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Mitochondrial genome and its regulator TFAM modulates head and neck tumourigenesis through intracellular metabolic reprogramming and activation of oncogenic effectors
Yi-Ta Hsieh et al.
CELL DEATH & DISEASE (2021)
Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct Mechanisms
Malene E. Lindholm et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)
Prohibitin 1 is essential to preserve mitochondria and myelin integrity in Schwann cells
Gustavo Della-Flora Nunes et al.
NATURE COMMUNICATIONS (2021)
Prohibitin-1 Is a Dynamically Regulated Blood Protein With Cardioprotective Effects in Sepsis
Taylor A. Mattox et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: A concise review
Lynn Htet Htet Aung et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Imine stilbene analog ameliorate isoproterenol-induced cardiac hypertrophy and hydrogen peroxide-induced apoptosis
Ganesh Kumar Raut et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
SOD2 deficiency in cardiomyocytes defines defective mitochondrial bioenergetics as a cause of lethal dilated cardiomyopathy
Sudha Sharma et al.
REDOX BIOLOGY (2020)
Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated CaV1.2 expression
Jung Woo Han et al.
CELL CALCIUM (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
Zheng Xiao et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
The mitochondrial effects of embelin are independent of its MAP kinase regulation: Role of p53 in conferring selectivity towards cancer cells
Deepa R. Avisetti et al.
MITOCHONDRION (2019)
Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse
R. Filograna et al.
SCIENCE ADVANCES (2019)
Glucose starvation-induced oxidative stress causes mitochondrial dysfunction and apoptosis via Prohibitin 1 upregulation in human breast cancer cells
Ganesh Kumar Raut et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Prohibitin is a positive modulator of mitochondrial function in PC12 cells under oxidative stress
Corey J. Anderson et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment
Jie Yang et al.
CELL DEATH & DISEASE (2018)
Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study
Mika Kivimaeki et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Prohibitin confers cytoprotection against ISO-induced hypertrophy in H9c2 cells via attenuation of oxidative stress and modulation of Akt/Gsk-3β signaling
Debabrata Chowdhury et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice
Niharika Amireddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Mitochondrial flashes regulate ATP homeostasis in the heart
Xianhua Wang et al.
ELIFE (2017)
Abrogating Mitochondrial Dynamics in Mouse Hearts Accelerates Mitochondrial Senescence
Moshi Song et al.
CELL METABOLISM (2017)
Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
Wen-qian Dong et al.
ONCOTARGET (2016)
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
Mitochondrial biogenesis and dynamics in the developing and diseased heart
Gerald W. Dorn et al.
GENES & DEVELOPMENT (2015)
miR-361-regulated prohibitin inhibits mitochondrial fission and apoptosis and protects heart from ischemia injury
K. Wang et al.
CELL DEATH AND DIFFERENTIATION (2015)
Enhanced Cardiac Akt/Protein Kinase B Signaling Contributes to Pathological Cardiac Hypertrophy in Part by Impairing Mitochondrial Function via Transcriptional Repression of Mitochondrion-Targeted Nuclear Genes
Adam R. Wende et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Kruppel-like Factor 4 Protein Regulates Isoproterenol-induced Cardiac Hypertrophy by Modulating Myocardin Expression and Activity
Tadashi Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement
Neha Jadeja Pagidipati et al.
CIRCULATION (2013)
Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats
Shiu-Min Cheng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial Infarction
Dieter A. Kubli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats
Debabrata Chowdhury et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Beta-Adrenergic Receptors, from Their Discovery and Characterization through Their Manipulation to Beneficial Clinical Application
S. Blake Wachter et al.
CARDIOLOGY (2012)
The role and therapeutic potential of prohibitin in disease
Arianne L. Theiss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy
E. Dale Abel et al.
CARDIOVASCULAR RESEARCH (2011)
The Progression of Hypertensive Heart Disease
Mark H. Drazner
CIRCULATION (2011)
Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease
Georgios Karamanlidis et al.
CIRCULATION-HEART FAILURE (2011)
Cellular mechanisms of cardiomyopathy
Pamela A. Harvey et al.
JOURNAL OF CELL BIOLOGY (2011)
Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase
Bettina Johanna Stuck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heart mitochondria:: gates of life and death
Asa B. Gustafsson et al.
CARDIOVASCULAR RESEARCH (2008)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization
R Chaturvedi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Metabolic gene expression in fetal and failing human heart
P Razeghi et al.
CIRCULATION (2001)
Global burden of cardiovascular diseases - Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies
S Yusuf et al.
CIRCULATION (2001)
Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins
LGJ Nijtmans et al.
EMBO JOURNAL (2000)
Share Paper
